Advanced therapeutic inhalation aerosols of a Nrf2 activator and RhoA/Rho kinase (ROCK) inhibitor for targeted pulmonary drug delivery in pulmonary hypertension: design, characterization, aerosolization, in vitro 2D/3D human lung cell cultures, and in vivo efficacy

Maria F. Acosta (Creator)
Priya Muralidharan (Creator)
Carissa L. Grijalva (Creator)
Michael D. Abrahamson (Creator)
Don Hayes (Creator)
Jeffrey R. Fineman (Creator)
Stephen M. Black (Creator)
Heidi M. Mansour (Creator)

Dataset

1 results

2021
Advanced therapeutic inhalation aerosols of a Nrf2 activator and RhoA/Rho kinase (ROCK) inhibitor for targeted pulmonary drug delivery in pulmonary hypertension: design, characterization, aerosolization, in vitro 2D/3D human lung cell cultures, and in vivo efficacy
Acosta, M. F., Muralidharan, P., Grijalva, C. L., Abrahamson, M. D., Hayes, D., Fineman, J. R., Black, S. M. & Mansour, H. M., 2021, In: Therapeutic Advances in Respiratory Disease. 15
Research output: Contribution to journal › Article › peer-review

Open Access
12 Link opens in a new tab Scopus citations